Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thyroid dysfunction in women with systemic sclerosis.

Bianca Marasini1, Pier Alda Ferrari, Nadia Solaro

  • 1Rheumatology Unit, Humanitas Clinical Institute, University of Milan, Milan, Italy.

Annals of the New York Academy of Sciences
|September 26, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Description and therapy of palmoplantar pustular psoriasis under IL-17A or dual IL-17A/F inhibition.

Journal of autoimmunity·2026
Same author

Combined immunosuppressive therapy in systemic sclerosis-associated interstitial lung disease: Phenotypes matter.

Autoimmunity reviews·2026
Same author

Real-world clinical experience with upadacitinib in a cohort of Italian patients with axial spondyloarthritis.

Frontiers in pharmacology·2026
Same author

Modulation of proinflammatory but not regulatory cytokines by in vitro JAK inhibition in peripheral blood B-cells of patients with psoriatic arthritis.

Journal of dermatological science·2026
Same author

Achievement and Maintenance of Remission with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in Italy: 1-Year Data from UPHOLD, a Prospective Real-World Observational Study.

Rheumatology and therapy·2026
Same author

Natural language processing to intercept rheumatoid and psoriatic arthritis from clinical notes in the Emergency Department.

Therapeutic advances in musculoskeletal disease·2026

Systemic sclerosis (SSc) does not independently increase thyroid dysfunction risk. However, antithyroid peroxidase antibodies indicate a higher risk for hypothyroidism in both SSc and osteoarthritis patients.

Area of Science:

  • Rheumatology
  • Endocrinology
  • Immunology

Background:

  • Hypothyroidism is frequently reported in systemic sclerosis (SSc), but its independent association with SSc remains debated.
  • Thyroid dysfunction screening in SSc patients is a topic of ongoing discussion.

Purpose of the Study:

  • To investigate whether systemic sclerosis (SSc) independently elevates the risk of thyroid dysfunction.
  • To determine the necessity of routine thyroid function screening in SSc patients.

Main Methods:

  • Serum thyroid function tests (free triiodothyronine, free thyroxine, thyroid-stimulating hormone) and thyroid autoantibodies (antithyroid peroxidase, antithyreoglobulin) were measured.
  • Compared 79 women with SSc against 81 age-matched women with osteoarthritis (OA) as controls.

Related Experiment Videos

Main Results:

  • Hypothyroidism prevalence was 20% in SSc and 11% in OA (P=0.131).
  • Antithyroid peroxidase antibodies were more frequent in SSc (23%) than OA (11%) (P=0.057).
  • The risk of hypothyroidism was significantly higher in antithyroid peroxidase-positive individuals, particularly in the OA group (OR=24.6) compared to the SSc group (OR=4.2).

Conclusions:

  • Systemic sclerosis (SSc) is not an independent risk factor for thyroid dysfunction.
  • Antithyroid peroxidase antibodies are a key indicator for identifying patients at risk of developing thyroid dysfunction, regardless of their primary condition.